Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Thrombosis Journal

Fig. 4

From: Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study

Fig. 4

Serial changes in coagulation tests in the early phase of DIC group and in the overt DIC group

Open circle: Severe coagulopathy group. Filled circle: Mild coagulopathy group.

Data are expressed as means ± standard deviation. Significant difference compared with the severe coagulopathy group. Significant difference compared with day 1.

Back to article page